Faculty of Pharmacy, Department of Pharmacology, Anadolu University, Eskişehir 26470, Turkey.
Faculty of Pharmacy, Department of Pharmaceutical Chemistry, Anadolu University, Eskişehir 26470, Turkey.
Molecules. 2021 Jun 2;26(11):3350. doi: 10.3390/molecules26113350.
In this study, we aimed to design and synthesize novel molecules carrying both the thiazole and piperazine rings in their structures and to investigate their antinociceptive activity. Targeted compounds were obtained by reacting thiosemicarbazide derivative and appropriate 2-bromoacetophenone in ethanol. The structures of the obtained compounds were determined using data from various spectroscopic methods (IR, H-NMR, C-NMR, and LCMSMS). Experimental data from in vivo tests showed that test compounds -, , and (50 mg/kg) significantly prolonged reaction times of animals in tail-clip and hot-plate tests compared to the controls, indicating that these compounds possess centrally mediated antinociceptive activities. Furthermore, these compounds reduced the number of writhing behaviors in the acetic acid-induced writhing tests, showing that the compounds also possess peripheral antinociceptive activity. In the mechanistic studies, naloxone pre-treatments abolished the antinociceptive activities of compounds -, , and , indicating that opioidergic mechanisms were involved in their antinociceptive effects. Molecular docking studies demonstrating significant interactions between the active compounds and µ- and δ-opioid receptor proteins supported the pharmacological findings. This study is the first showing that molecules designed to bear thiazole and piperazine moieties together on their structure exert centrally and peripherally mediated antinociceptive effects by activating the opioid system.
在这项研究中,我们旨在设计和合成新型分子,其结构中同时含有噻唑环和哌嗪环,并研究它们的镇痛活性。目标化合物是通过将硫代氨基脲衍生物和适当的 2-溴苯乙酮在乙醇中反应得到的。通过各种光谱方法(IR、H-NMR、C-NMR 和 LCMSMS)获得的化合物结构进行了确定。体内试验的实验数据表明,与对照组相比,测试化合物- 、 和 (50mg/kg)显著延长了动物在尾部夹和热板试验中的反应时间,表明这些化合物具有中枢介导的镇痛活性。此外,这些化合物还减少了醋酸诱导的扭体试验中的扭体行为的数量,表明这些化合物还具有外周镇痛活性。在机制研究中,纳洛酮预处理消除了化合物- 、 和 的镇痛活性,表明阿片类机制参与了它们的镇痛作用。分子对接研究表明,活性化合物与μ和δ阿片受体蛋白之间存在显著的相互作用,支持了药理学发现。这项研究首次表明,设计成在其结构上同时承载噻唑和哌嗪部分的分子通过激活阿片系统发挥中枢和外周介导的镇痛作用。